FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11267511000001101: Cefalexin 250mg tablets (Pliva Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
40565301000001117 Cefalexin 250mg tablets (Pliva Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42061501000001119 Cefalexin 250mg tablets (PLIVA Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Is a Cefalexin 250mg tablets true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Is a Cefalexin 250mg tablets false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Is a Product containing precisely cefalexin monohydrate 250 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has active ingredient Cefalexin false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has specific active ingredient Cefalexin true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has active ingredient Cefalexin monohydrate false Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Cefalexin 250mg tablets (Pliva Pharma Ltd) 28 tablet 4 x 7 tablets Is pack of False Cefalexin 250mg tablets (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier
Cefalexin 250mg tablets (Pliva Pharma Ltd) 28 tablet 4 x 7 tablets Has AMP True Cefalexin 250mg tablets (Pliva Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start